Mar 01, 2019

Advancing Hematologic Cancer Research and Care

The Center of Excellence in Hematologic Malignancies and Hematology at Huntsman Cancer Institute is a group of more than three dozen doctors and scientists dedicated to hematologic cancers such as leukemia, lymphoma, and multiple myeloma. Integration and collaboration across disciplines will improve clinical care and advance research in these complicated diseases.

Sep 18, 2018

Talks with Docs: Deborah Stephens, DO

Dr. Deborah Stephens cares for patients with lymphoma and chronic lymphocytic leukemia and researches these diseases. In this episode of Talks with Docs, she shares the importance of caring for the whole patient and how becoming a parent has changed her.

May 23, 2018

Huntsman Translational Scholars: Deborah Stephens, DO

HCI established the Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Deborah Stephens, DO, was recently honored with a Huntsman Translational Scholar award. She is the physician leader of Hematology Clinical Trials at Huntsman Cancer Institute and is also an assistant professor in the Division of Hematology and Hematologic Malignancies at the University of Utah.

May 10, 2018

Huntsman Cancer Institute First Adult Cancer Hospital in Mountain West to Offer CAR T Cell Therapy to Patients

Huntsman Cancer Institute announced today that it has been certified to offer both chimeric antigen receptor (CAR) T cell therapies recently approved by the U.S. Food and Drug Administration. The therapies are approved for types of aggressive blood cancers, including B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma. HCI is one of a few locations nationwide, and the only in the Mountain West, approved to offer these new therapies to adult cancer patients.

Feb 15, 2018

Navigating Cancer at a Young Age

For many of young people, a cancer diagnosis is their first real medical issue. This was the case for Marina Pimentel, who was diagnosed with Hodgkin lymphoma, a type of blood cancer, at age 26. Marina worked with an AYA patient navigator to help her manage the complexities of cancer treatment and care.

Feb 01, 2018

Photopheresis: Using Light to Alter the Immune System

Photopheresis treatment seems to modulate the immune system, not suppress it, allowing the body to manage graft-versus-host disease without counteracting the effects of the hematopoietic stem cell transplant.

Aug 09, 2017

Talks with Docs: John Sweetenham, MD

John Sweetenham, MD, shares his experience of growing up in England, what other profession he might have liked to practice, and more.